Amgen files Lawsuit against Sanofi and Regeneron for patent infringement
These patents, which are owned by Amgen, describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 ("PCSK9"). By its complaint, Amgen seeks an injunction to prevent